Kamal Joshi

Principal Scientist, Bristol Myers Squibb

Kamal Joshi is listed as Principal Scientist, Bristol Myers Squibb. Kamal is scheduled to speak at Festival of Biologics USA on 14 April 2027.

Compiled from published conference agendas; not yet confirmed by Kamal. Is this you? Claim this profile.

About

Kamal Joshi is a Principal Scientist and Group Leader in Discovery Biotherapeutics at Bristol Myers Squibb (BMS), where he leads the development of next-generation multispecific antibodies and T-cell engager therapies for cancer. His work focuses on protein engineering, antibody discovery, and AI-enabled biologics innovation to advance novel immunotherapies. Prior to BMS, he conducted antibody engineering research at Genentech and earned his Ph.D. in Biochemistry and Molecular Biology from the University of Massachusetts Amherst.

Upcoming

Festival of Biologics USA 13 April 2027 – 14 April 2027

Engineering Next-Generation T-Cell Engagers for Solid Tumors Speaker · 14 April 2027